3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
35
Lung Neoplasms
9
Neoplasms
6
Neoplasm Metastasis
5
Carcinoma
5
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thoracic Neoplasms
1
Stage IB-IIIA Non-small Cell Lung Carcinoma
1
Skin Neoplasms
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Prostatic Neoplasms
1
Noonan Syndrome
1
Non Small Cell Lung Cancer Metastatic
1
Neoplasms, Squamous Cell
1
Neoplasms by Site
1
NSCLC
1
Multiple Myeloma
1
Lymphoma
1
Lung Diseases
1
Locally Advanced or Metastatic EGFR T790M+ NSCLC
1
Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
1
Hematologic Neoplasms
1
Gastrointestinal Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Squamous Cell
1
Interventions
Dexamethasone
43
Cyclophosphamide
38
fludarabine phosphate
27
Cytarabine
26
Rituximab
24
Methotrexate
21
Lenalidomide
21
Bortezomib
21
Calcium Dobesilate
20
fludarabine
19
Peripheral Blood Stem Cell Transplantation
19
Whole-Body Irradiation
16
Mycophenolic Acid
16
pembrolizumab
15
Gemcitabine
15
Etoposide
15
pomalidomide
14
Melphalan
14
Vincristine
13
Filgrastim
13
Busulfan
13
Tacrolimus
12
Cyclosporine
12
Carboplatin
12
Paclitaxel
11
carfilzomib
10
durvalumab
9
Doxorubicin
9
Cetuximab
9
Brentuximab Vedotin
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Recurrence
×
osimertinib
×
Clear all
No trials found.